Vivo aims for Asia healthcare investments, with $275M fund
See David Hamilton’s story, over at VentureBeat Life Sciences
Next Story: Stubbing out tobacco-funded research — is it all for the good?
Previous Story: Coattail Ventures strikes again, backs StrongMail with $13M
About the Author, Matt Marshall
Matt Marshall is editor and CEO of VentureBeat. Follow him on Twitter at @mmarshall, and follow VentureBeat on Twitter at @venturebeat.